Lanean...
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Cancer immunotherapy has veered the paradigm of cancer treatment. Despite recent advances in immunotherapy for improved antitumor efficacy, the complicated tumor microenvironment (TME) is highly immunosuppressive, yielding both astounding and unsatisfactory clinical successes. In this regard, clinic...
Gorde:
| Argitaratua izan da: | Acta Pharm Sin B |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714985/ https://ncbi.nlm.nih.gov/pubmed/33304779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.08.010 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|